TCG Crossover
Palo Alto, Californiatcgcrossover.com
Overview
TCG Crossover is a science-driven investment firm focused on the healthcare sector. The company invests in private and public companies and supports visionary entrepreneurs leveraging recent scientific breakthroughs to develop transformative medicines. With offices in Palo Alto, San Francisco, and New York City, they have global capabilities and have supported companies in North America, Europe, and China.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Vaderis Therapeutics | Aug 2026 | Series B | Lead |
| Ollin Biosciences | Jun 2026 | Series B | Lead |
| Accro Bioscience Inc. | May 2026 | Series C | Co-investor |
| Accro Bioscience | May 2026 | Series C | Co-investor |
| Obsidian Therapeutics | Apr 2026 | Private Equity | Co-investor |
Key People
Dandan Dong
Venture Partner
Cariad Chester
Partner
Giuliano Marostica
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
